(19)
(11) EP 4 815 924 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817972.3

(22) Date of filing: 03.12.2024
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 9/00(2006.01)
A61K 9/16(2006.01)
 A61K 45/06(2006.01)
A23L 33/00(2016.01)
A61K 47/34(2017.01)
(52) Cooperative Patent Classification (CPC):
A23L 33/30; A61K 9/1652; A61K 9/0095; A61K 47/34; A23L 33/10; A61K 31/7004
(86) International application number:
PCT/EP2024/084582
(87) International publication number:
WO 2025/119939 (12.06.2025 Gazette 2025/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.12.2023 EP 23213854
21.12.2023 LU 103233

(71) Applicant: Aphaia Pharma AG
6300 Zug (CH)

(72) Inventor:
  • BOLZ, Steffen-Sebastian
    82211 Herrschning (DE)

(74) Representative: Habermann, Hruschka & Schnabel 
Patentanwälte Montgelasstraße 2
81679 München
81679 München (DE)

   


(54) TREATMENT OF OBESITY AND RELATED CONDITIONS BY CIRCADIAN ADMINISTRATION OF ENTEROKINE-STIMULATING COMPOSITIONS